Myda Advisors LLC Karuna Therapeutics, Inc. Transaction History

Myda Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$164.66 - $218.08 $164,660 - $218,080	-1,000 Reduced 14.29%	6,000 $1.01 Million
Q2 2023 Aug 11, 2023	SELL	$176.32 - $240.22 $176,320 - $240,220	-1,000 Reduced 12.5%	7,000 $1.52 Million
Q1 2023 May 12, 2023	BUY	$161.33 - $204.36 $1.29 Million - $1.63 Million	8,000 New	8,000 $1.45 Million
Q1 2020 May 14, 2020	SELL	$60.41 - $115.92 $543,690 - $1.04 Million	-9,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$11.44 - $123.99 $102,960 - $1.12 Million	9,000 New	9,000 $678,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Myda Advisors LLC with notifications on news.